Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-26T08:19:03.179Z Has data issue: false hasContentIssue false

Urinary Catecholamine Levels and Response to Group Cognitive Behaviour Therapy in Depression

Published online by Cambridge University Press:  26 March 2010

Tian P. S. Oei*
Affiliation:
University of Queensland and Toowong Private Hospital, Brisbane, Australia
Genevieve A. Dingle
Affiliation:
University of Queensland, Australia
Molly McCarthy
Affiliation:
University of Queensland, Australia
*
Reprint requests to Tian Po Oei, School of Psychology, The University of Queensland, Brisbane, Queensland 4072, Australia. E-mail: [email protected] An extended version is also available online in the table of contents for this issue: http://journals.cambridge.org/jid_BCP

Abstract

Aim: The aim was to investigate whether high catecholamine (CA) excreters would respond less well to a group cognitive behaviour therapy (CBT) treatment for depression than others. Method: A sample of 70 adults with depression symptoms participated in a 12-week course of group CBT. Participants’ 24 hour urinary catecholamine levels at pre-therapy and post-therapy were used to classify them as High (N = 10); Low (N = 33) or Mixed (N = 27) according to a cut-off one standard deviation above a published mean for healthy adults. Beck Depression Inventory (BDI) and cognitions questionnaire (Automatic Thoughts Questionnaire; Beck Hopelessness Scale and Dysfunctional Attitudes Scale) were used. Results: Repeated measures ANOVA analyses showed an equal rate of mood improvement in all three groups over the course of CBT, despite the fact that the High excreters were on average more depressed throughout the study. Changes in depression symptoms were mirrored by improvements in cognitive measures in the three catecholamine groups. Conclusion: This study indicates that adults showing a biological marker of depression (elevated catecholamine levels) are equally able to benefit from CBT treatment as adults without this marker.

Type
Research Article
Copyright
Copyright © British Association for Behavioural and Cognitive Psychotherapies 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Davis, J. M., Koslow, S. H., Gibbons, R. D., Maas, J. W., Bowden, C. L., Casper, R., Hanin, I., Javaid, J. I., Chang, S. and Stokes, P. E. (1988). Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls. Archives of General Psychiatry, 45, 705717.CrossRefGoogle ScholarPubMed
Fochtmann, L. J. and Gelenberg, A. J. (2005). Guideline Watch: practice guideline for the treatment of patients with major depressive disorder (2nd ed.). Arlington, VA: American Psychiatric Association.Google Scholar
Hughes, J. W., Watkins, L., Blumenthal, J. A., Kuhn, C. and Sherwood, A. (2004). Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. Journal of Psychosomatic Research, 57, 353358.CrossRefGoogle ScholarPubMed
Nemeroff, C. B. and Vale, W. W. (2005). The neurobiology of depression: inroads to treatment and new drug discovery. Journal of Clinical Psychiatry, 66 (suppl 7), 513.Google ScholarPubMed
Oei, T. P. S. and Dingle, G. (2001). Cognitive and biochemical processes in depressed adult outpatients: a test of the circular process model. Journal of Behavior Therapy and Experimental Psychiatry, 32, 91104.CrossRefGoogle ScholarPubMed
Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders: a review of supporting evidence. Journal of Psychiatry, 122, 509522.Google ScholarPubMed
Supplementary material: File

Oei supplementary material

Extended report.doc

Download Oei supplementary material(File)
File 439.8 KB
Submit a response

Comments

No Comments have been published for this article.